- Novel three?lncRNA signature predicts survival in patients with pancreatic cancer.
Wu Bin et al. Oncology reports 2018 Dec 40(6) 3427-3437
- Are BRCA1 and BRCA2 gene mutation patients underscreened for pancreatic adenocarcinoma?
Roch Alexandra M et al. Journal of surgical oncology 2019 Jan
- Closing the Disparity in Pancreatic Cancer Outcomes: A Closer Look at Nonmodifiable Factors and Their Potential Use in Treatment.
Vick Alexis D et al. Pancreas 2019 Jan
- Should Researchers Offer Results to Family Members of Cancer Biobank Participants? A Mixed-Methods Study of Proband and Family Preferences.
Gordon Deborah R et al. AJOB empirical bioethics 2018 Dec 1-22
- Current Approaches to Pancreatic Cancer Screening.
Chhoda Ankit et al. The American journal of pathology 2019 Jan 189(1) 22-35
- MicroRNAs in pancreatic cancer diagnosis and therapy.
Slotwinski Robert et al. Central-European journal of immunology 2018 43(3) 314-324
- Multicenter experience with large panel next-generation sequencing in patients with advanced solid cancers in Japan.
Kato Shingo et al. Japanese journal of clinical oncology 2018 Dec
- 5 Things to Know About Hereditary Pancreatic Cancer
Pancreatic Cancer Action Network, November 2018
- A Novel Multiplex droplet digital PCR Assay to Identify and Quantify KRAS Mutations in Clinical Specimens.
Alcaide Miguel et al. The Journal of molecular diagnostics : JMD 2018 Nov
- Evaluating Susceptibility to Pancreatic Cancer: ASCO Provisional Clinical Opinion.
Stoffel Elena M et al. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2018 Nov JCO1801489
domingo, 20 de enero de 2019
Pancreatic Cancer Genomics - Cancer PHGKB -
Pancreatic Cancer Genomics
- Cancer PHGKB -
Last Posted: Jan 17, 2019